These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 11008120)
1. The stimulatory effects of cationic amphiphilic drugs on human platelets treated with thrombin. Tharmapathy P; Fukami MH; Holmsen H Biochem Pharmacol; 2000 Nov; 60(9):1267-77. PubMed ID: 11008120 [TBL] [Abstract][Full Text] [Related]
2. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets. Ryningen A; Olav Jensen B; Holmsen H Biochim Biophys Acta; 1998 Nov; 1394(2-3):235-48. PubMed ID: 9795233 [TBL] [Abstract][Full Text] [Related]
3. Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism. Steen VM; Tysnes OB; Holmsen H Biochem J; 1988 Jul; 253(2):581-6. PubMed ID: 2845924 [TBL] [Abstract][Full Text] [Related]
4. Thrombin-induced abnormal platelet activation in spontaneously hypertensive rats is linked with phosphoinositides turnover and phosphorylation of 47,000 and 20,000 dalton proteins. Huzoor-Akbar ; Anwer K Thromb Res; 1988 Jan; 49(1):5-21. PubMed ID: 2831638 [TBL] [Abstract][Full Text] [Related]
5. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets. Vickers JD J Pharmacol Exp Ther; 1993 Sep; 266(3):1156-63. PubMed ID: 8396627 [TBL] [Abstract][Full Text] [Related]
6. Effect of antidepressants and neuroleptics on phosphoinositide metabolism in human platelets. Pandey SC; Davis JM; Schwertz DW; Pandey GN J Pharmacol Exp Ther; 1991 Mar; 256(3):1010-8. PubMed ID: 1672374 [TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide metabolism in resting and thrombin-stimulated human platelets. Evidence against metabolic heterogeneity. Tysnes OB; Verhoeven AJ; Aarbakke GM; Holmsen H FEBS Lett; 1987 Jun; 218(1):68-72. PubMed ID: 3036588 [TBL] [Abstract][Full Text] [Related]
8. Platelet activity and phosphoinositide turnover increase with advancing age. Bastyr EJ; Kadrofske MM; Vinik AI Am J Med; 1990 Jun; 88(6):601-6. PubMed ID: 2161185 [TBL] [Abstract][Full Text] [Related]
9. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM. Bastyr EJ; Kadrofske MM; Dershimer RC; Vinik AI Diabetes; 1989 Sep; 38(9):1097-102. PubMed ID: 2548908 [TBL] [Abstract][Full Text] [Related]
10. Phosphate turnover of phosphatidylinositol in resting and thrombin-stimulated platelets. Tysnes OB; Verhoeven AJ; Holmsen H Biochim Biophys Acta; 1986 Nov; 889(2):183-91. PubMed ID: 3022825 [TBL] [Abstract][Full Text] [Related]
11. Effect of chlorpromazine on inositol-lipid signalling system in human thrombocytes. Strunecká A; Rípová D; Folk P Physiol Bohemoslov; 1987; 36(6):495-501. PubMed ID: 2830631 [TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide interconversion in thrombin-stimulated human platelets. Wilson DB; Neufeld EJ; Majerus PW J Biol Chem; 1985 Jan; 260(2):1046-51. PubMed ID: 2981829 [TBL] [Abstract][Full Text] [Related]
13. Changes in the platelet phosphoinositides during the first minute after stimulation of washed rabbit platelets with thrombin. Vickers JD; Kinlough-Rathbone RL; Mustard JF Biochem J; 1984 Apr; 219(1):25-31. PubMed ID: 6326756 [TBL] [Abstract][Full Text] [Related]
14. Psychotropic drugs interfere with the tight coupling of polyphosphoinositide cycle metabolites in human platelets: a result of receptor-independent drug intercalation in the plasma membrane? Oruch R; Hodneland E; Pryme IF; Holmsen H Biochim Biophys Acta; 2008 Oct; 1778(10):2165-76. PubMed ID: 18503745 [TBL] [Abstract][Full Text] [Related]
15. Identification of minor metabolites of phospholipid signal molecules in [(32)P]P(i)-labelled platelets. Iversen H; Fuglebakk E; Holmsen H; Fukami MH Platelets; 2002; 13(5-6):279-84. PubMed ID: 12189013 [TBL] [Abstract][Full Text] [Related]
16. Possible regulation of phospholipase C activity in human platelets by phosphatidylinositol 4',5'-bisphosphate. Graff G; Nahas N; Nikolopoulou M; Natarajan V; Schmid HH Arch Biochem Biophys; 1984 Jan; 228(1):299-308. PubMed ID: 6320736 [TBL] [Abstract][Full Text] [Related]
17. Neomycin inhibits agonist-stimulated polyphosphoinositide metabolism and responses in human platelets. Tysnes OB; Verhoeven AJ; Holmsen H Biochem Biophys Res Commun; 1987 Apr; 144(1):454-62. PubMed ID: 3034251 [TBL] [Abstract][Full Text] [Related]
18. The aggregation of human platelet induced by ganodermic acid S. Wang CN; Chen JC; Shiao MS; Wang CT Biochim Biophys Acta; 1989 Nov; 986(1):151-60. PubMed ID: 2819092 [TBL] [Abstract][Full Text] [Related]
19. Evidence for tight metabolic control of the receptor-activated polyphosphoinositide cycle in human platelets. Steen VM; Tysnes OB; Holmsen H Biochem J; 1989 Oct; 263(2):621-4. PubMed ID: 2557003 [TBL] [Abstract][Full Text] [Related]
20. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation. Vickers JD; Kinlough-Rathbone RL; Mustard JF Biochem J; 1986 Jul; 237(2):327-32. PubMed ID: 3026316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]